Navigation Links
New Study: Improved Immune System with Gene-Eden, a Natural Antiviral Supplement that Targets Chronic Viruses
Date:3/1/2010

New study revealed that the antiviral supplement Gene-Eden caused a complete recovery of the immune system and an amazing 34% reduction in tumor size in a patient with pancreatic cancer treated with second-line chemotherapy that is used for relieving symptoms rather than shrinking tumor.

(PRWEB) March 1, 2010 -- New study revealed that treatment with the natural antiviral supplement Gene-Eden caused a complete recovery of the immune system and an amazing 34% reduction in tumor size in a patient with pancreatic cancer. The study, which was conducted at the Center for the Biology of Chronic Disease by Hanan Polansky and Ido Dafni, was recently published in Acta Oncologica, a leading scientific journal in clinical oncology and related disciplines, and the official journal of the five Nordic oncological societies.

Pancreatic cancer is one of the most aggressive types of cancer and is very resistant to medical treatment. In United States alone, physicians diagnose more than 40,000 new cases each year, and more than 35,000 die from it annually. The common treatments include surgical removal of the tumor (only for localized disease), chemotherapy, and radiation therapy. The tragedy is that these treatments have a limited impact on the progression of the disease, and as a result, less than 5 percent of the patients are still alive five years after diagnosis. Complete remission is very rare.

The patient in the study was a 61 years old female, who was diagnosed with an inoperable pancreatic carcinoma. After two months of chemotherapy, which had no effect on the tumor growth, yet caused a sharp decline the number of immune cells, the treatment was replaced with a second-line chemotherapy, which is used for relieving symptoms rather than shrinking tumor. In addition, the patient was treated with Gene-Eden. Five weeks later, to the great surprise of the medical staff, a CT scan and some blood tests showed that the tumor shrank by 34%, and that the number of immune cells returned normal levels!

Gene-Eden is a broad range antiviral supplement that targets viruses during their latent or chronic phase. The development of Gene-Eden was inspired by Hanan Polansky’s discovery of the Starved Gene phenomenon. According to Polansky, common viruses, such as the Hepatitis Virus, Epstein Barr Virus (EBV), Cytomegalovirus (CMV), and Herpes Simplex Virus (HSV), are genetic parasites. After they plant themselves in the nucleus, they “steal” needed resourced from the human genes. The starved human genes produce less proteins, such as Retinoblastoma (Rb) and BRCA1, and the cell can no longer control its rate of replication. The result is excessive cell replication and development of tumors.

For a more detailed explanation of the Starved Gene discovery, specifically formulated for the general public, see http://www.gene-eden.com/Gene-Eden.htm.

According to the Starved Gene phenomenon, chronic viruses can cause many major diseases, and specifically pancreatic cancer, and an antiviral treatment that targets chronic viruses should be effective in treating the disease. According to the authors of the study, the results suggest that by targeting the chronic viruses in the patient’s body, Gene-Eden contributed to the surprising improvement in the patient’s condition.

For more information on Gene-Eden, visit http://www.gene-eden.com. Gene-Eden is available on Amazon.com.

Study: “Gene-Eden, a broad range, natural antiviral supplement, may shrink tumors and strengthen the immune system” Hanan Polansky, Ido Dafni. Acta Oncologica; Posted online on 8 Jan 2010.

# # #

Read the full story at http://www.prweb.com/releases/Gene-Eden/Improved-Immune-System/prweb3646994.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. U of M study: Early treatment can reverse heart damage
2. New study: Pine bark reduces perimenopausal symptoms
3. U of M study: Health food supplement may curb addiction of pathological gamblers
4. New study: Pine bark extract reduces ADHD symptoms in children
5. Kaiser Permanente study: Alcohol amount, not type -- wine, beer, liquor -- triggers breast cancer
6. UGA study: Youth exposed to smokeless tobacco ads despite settlement
7. New National Medicaid Study: Minnesota Under Funds Seniors Nursing Home Care $167 Million Annually
8. Study: Modafinil is effective in treating excessive sleepiness
9. Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume
10. New study: pine bark extract boosts nitric oxide production
11. Study: HPV test beats Pap in detecting cervical cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Study: Improved Immune System with Gene-Eden, a Natural Antiviral Supplement that Targets Chronic Viruses 
(Date:2/9/2016)... ... February 09, 2016 , ... METTLER ... ensure lab personnel have a basic understanding of the techniques they use so ... understanding will help them reduce waste and rework to create a leaner overall ...
(Date:2/9/2016)... Santa Rosa, California (PRWEB) , ... February 09, 2016 , ... ... been rated one of the highest preliminary data vendors in the latest KLAS report, ... 15 years, i2i has led the developing market for population health management (PHM). ...
(Date:2/8/2016)... Bethlehem, PA (PRWEB) , ... February 08, 2016 ... ... announce expanded authorization with BASF Human Nutrition into the Food & Beverage ... BSI has been BASF’s channel partner throughout Canada and USA geographies east ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... packer for pouches, bags, and flow wrapped products at WestPack 2015, February 9-11, ... product manufacturers step up to semi-automatic or fully-automatic case packing with a small ...
(Date:2/8/2016)... Venice, FL (PRWEB) , ... February 08, 2016 ... ... their new community enrichment program serving the greater Venice, FL area, has initiated ... died tragically in a car accident just four days after Christmas. To support ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)...  Misonix, Inc. (NASDAQ: MSON ), an ... markets innovative therapeutic ultrasonic products for spine surgery, ... surgery and other surgical applications, today announced financial ... half of fiscal year 2016 ended December 31, ... --> Highlights for the second quarter and ...
(Date:2/9/2016)... YORK, Pa., Feb. 9, 2016  Unilife Corporation ("Unilife" or "Company") ... of injectable drug delivery systems, today announced its financial results for ... 2015). ... Revenue for the ... million in the same period last year.  Cash receipts from customers ...
(Date:2/9/2016)... Feb. 9, 2016  Jazz Pharmaceuticals plc (Nasdaq: ... 2015 fourth quarter and full year financial results on ... financial markets.  Company management will host a live audio ... p.m. GMT to discuss fourth quarter and full year ... update and guidance for 2016 financial results. ...
Breaking Medicine Technology: